On January 2025, President Donald Trump signed an executive order significantly impacting transgender youth’s access to gender-affirming medical care in the United States. The directive called for federal agencies to restrict such access for individuals under 19 and halt federal funding for these treatments.
Starting in 2026, the executive order mandates federal health programs to cease covering gender-affirming surgeries and hormone therapies for minors. Notably, it tasks the Department of Health and Human Services (HHS) with reevaluating and rescinding its 2022 guidance on gender-affirming care and demands medical institutions with federal research grants stop providing these services to young individuals.
Additionally, the order requests the Department of Justice (DOJ) to prioritize investigations into potential consumer fraud regarding long-term effects of these treatments. It also seeks protections for employees willing to report noncompliance by their colleagues and suggests the DOJ collaborate with Congress on creating a private right of action for those affected.
HHS has been directed to conduct a literature review on treatment options for transgender minors, termed as “children who assert gender dysphoria, rapid-onset gender dysphoria, or other identity-based confusion,” within a 90-day window. Progress reports are expected from various agencies within 60 days, with implementation timelines differing across sectors.
The move comes amidst a broader national discourse on transgender rights and healthcare access, intensifying during the 2024 election season. Research indicates that transgender individuals face substantial healthcare access barriers, with 22% lacking insurance coverage entirely. The Human Rights Campaign notes that many transgender youth often struggle to obtain necessary medical care and support services.
Despite growing public support for transgender rights over recent years, challenges persist. The community continues to encounter high rates of poverty, employment and housing discrimination, and difficulties in securing accurate identity documentation.
The executive order’s implementation and potential effects on transgender youth and its legal contestation will likely remain points of contention within the ongoing debate over LGBTQ rights in the United States. For the full article, visit JURIST’s website.